The PEC-001 Study

The My PEComa/PEC-001 clinical research study is for men and women over the age of 18, diagnosed with advanced malignant perivascular epithelioid cell cancer or PEComa.
This study will evaluate the safety and potential benefits of using an investigational medication to treat your disease. Everyone in the study will receive the same investigational medication.
A total of approximately 30 patients will participate in approximately 9 study centers in the United States.
For more information
For more information regarding the study please visit the website by following the link
If you are interested in participating in the study or have questions about the study, please contact Katie Riebe at (919) 271-0150 or